To support the idea of decreased activity of ACE2 in ARDS, the recombinant ACE2 shows activity on decreasing the occurrence of ARDS symptoms in murine [109] and rat [110] models induced by acid aspiration or lipopolysaccharide (LPS). Here, ACE2 is linked to acute respiratory distress syndrome.